Abstract
The ongoing use of direct oral anticoagulant therapy versus warfarin in individuals with varying renal function is challenging. The degree of renal function variability, the context in which renal function changes occur, and other patient and provider-specific factors must be carefully evaluated when assessing the benefits and risks of ongoing direct oral anticoagulant therapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nutescu EA, Burnett A, Fanikos J, et al. Pharmacology of anticoagulants used in the treatment of venous thromboembolism. J Thromb Thrombolysis. 2016;41(1):15–31.
Garcia DA, Baglin TP, Weitz JI, et al. Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e24S–43S.
Smythe MA, Priziola J, Dobesh PP, et al. Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism. J Thromb Thrombolysis. 2016;41(1):165–86.
Burnett AE, Mahan CE, Vazquez SR, et al. Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment. J Thromb Thrombolysis. 2016;41(1):206–32.
Cuker A, Siegal DM, Crowther MA, et al. Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulants. J Am Coll Cardiol. 2014;64(11):1128–39.
Pradaxa (dabigatran) package insert. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc; 2015.
Xarelto (rivaroxaban) package insert. Titusville, NJ: Janssen Pharmaceuticals, Inc; 2016.
Eliquis package insert. Princeton, NJ: Bristol-Myers Squibb Company; 2016.
Savaysa (edoxaban) package insert. Parsippany, NJ: Daiichi Sankyo, Inc; 2016.
Ageno W, Gallus AS, Wittkowsky A, et al. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e44S–88S.
January CT, Wann SL, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary. J Am Coll Cardiol. 2014;64(21):2246–80.
Dager W, Hellwig T. Current knowledge on assessing the effects of and managing bleeding and urgent procedures with direct oral anticoagulants. Am J Health Syst Pharm. 2016;73(10 Suppl 2):S14–26.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Lee, J.C. (2017). Oral Anticoagulants in Patients with Variable Renal Function. In: Kiser, K. (eds) Oral Anticoagulation Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-54643-8_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-54643-8_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-54641-4
Online ISBN: 978-3-319-54643-8
eBook Packages: MedicineMedicine (R0)